A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
NCT07765888
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
375
Enrollment
INDUSTRY
Sponsor class
Conditions
Atopic Dermatitis
Interventions
DRUG:
Tilrekimig
DRUG:
Placebo
Sponsor
Pfizer